SCHEMBL19950808

SCHEMBL19950808

ON=CNc1cc(Cl)cc(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19950807 1.00 — —
SCHEMBL19958207 0.76 KDM4E (0.42) —
SCHEMBL2771920 0.75 — —
SCHEMBL28797373 0.73 FGFR4 (0.41) —
SCHEMBL19958205 0.71 CA12 (0.41) —
SCHEMBL21922822 0.67 NOS3 (0.41) —
SCHEMBL18103976 0.67 ALDH1A1 (0.42) —
SCHEMBL12127970 0.67 TRPM8 (0.39) —
SCHEMBL28797376 0.67 L3MBTL1 (0.50) —
SCHEMBL29693275 0.67 L3MBTL1 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287286-B2 Compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-05-14 — — US disclosed
US-10287286-B2 Compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-05-14 — — US disclosed
US-20180072714-A1 Novel Compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-03-15 — — US disclosed
US-20180072714-A1 Novel Compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-03-15 — — US disclosed
US-20180072714-A1 Novel Compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-03-15 — — US disclosed
Send feedback